In the December issue of Clinical Chemistry, investigators at Duke University and the California Department of Health Services report on a new test for newborn screening that can be performed within the time allowed for hospital stays under early discharge policies and can detect a wider range of congenital disorders.
The metabolic autopsy may now provide answers to some sudden infant death syndrome (SIDS) cases.
In the wake of recent terrorist attacks, clinical laboratories need to re-examine their preparedness for natural and terrorist disasters. This audioconference is a unique opportunity to find out what laboratories need to do meet the challenge.
Learn about medicare reform and changes to lab reimbursement.
AACC Presents the Seventh Annual: Managing Your Point-of-Care Testing Program for Success. This practical three-part audioconference, providing critical information needed to make the right decisions on point-of-care testing, will be presented on January 23, 30, and February 6, 2002.
A must-attend conference for all clinicians, laboratorians and other health care professionals in the field of cardiac risk assessment! Explore together the best methods of diagnosing, monitoring and managing cardiac diseases.
The American Association for Clinical Chemistry is offering this two-day annual conference, providing critical information on new advances in cancer detection and monitoring, on April 25-26, 2002 at the Hilton La Jolla Torrey Pines in La Jolla, CA.
Our leading experts will address the most challenging issues facing the laboratory industry and share their visions with you. You will be able to invigorate your organization with new strategies that will allow you to successfully compete in today's complex and dynamic environment.
On Tuesday, April 30, 2002; 2:00 pm-3:15 pm EST, The American Association for Clinical Chemistry and The American Society for Clinical Laboratory Science will provide a timely and useful audioconference on how to implement the new medical privacy standards.
The American Association for Clinical Chemistry (AACC) organized an audioconference on what clinical laboratories need to know about chemical and bioterrorism on Wednesday, December 12, 2001. The proceeds, totaling $4,000, were donated to the Salvation Army.
The American Association for Clinical Chemistry is offering this critical conference, providing vital information regarding pharmacogenomics, on May 9-10, 2002, at the Double Tree Hotel in Philadelphia, PA.
On May 15, 2002, The American Association for Clinical Chemistry is offering this critical and timely audioconference, providing vital information on how the new, evidence-based diabetes testing guidelines will affect laboratories and patients.
Eleftherios P. Diamandis, MD, PhD, Mount Sinai Hospital, Toronto, Ontario, Canada will discuss the latest advances in cancer testing at the American Association for Clinical Chemistry's "Lab 2005" conference, being held at the Marriott Marquis, New York, N.Y. on March 21-22.
Jimmie Valentine, PhD, using US Army sponsorship, is developing a series of urine tests for exposure to chemical agents which he will discuss at the American Association for Clinical Chemistry's conference, "Lab 2005: Your Path to the Future," March 21-22, in New York City.
On July 17, 2002, The American Association for Clinical Chemistry (AACC) is offering this critical and timely audioconference, providing vital information on how the new, evidence-based chronic kidney disease testing guidelines will affect laboratories and patients.
The American Association for Clinical Chemistry has announced the launch of "Young's Effects Online," offering instant access to the effects of thousands of diseases, drugs, and herbal remedies on medical lab tests.
New research appearing online today in Clinical Chemistry, the journal of AACC, shows that a handheld mobile device can check patients’ HIV status with just a finger prick, and synchronize the results in real time with electronic health records. This technology takes a step toward providing remote areas of the world with diagnostic services traditionally available only in centralized healthcare settings.
Clinical Chemistry, the journal of AACC, has published a special issue devoted to the subject of cancer. With cancer surpassing cardiovascular disease as the number one killer in the Western world, the issue provides a cutting edge update on the state of cancer research in laboratory medicine today. The issue includes nearly 50 articles covering a wide range of topics, including companion diagnostics, the modeling of cancer initiation and progression, novel cancer therapies such as chemoprevention and targeting the tumor microenvironment, and the potential of genomics and metabolomics to improve personalized cancer management.
The Board of Directors of the American Association for Clinical Chemistry (AACC) today announced that it has appointed Janet B. Kreizman Chief Executive Officer effective April 1, 2013.
New research appearing online today shows that cannabis can be detected in the blood of daily smokers for a month after last intake. The scientific data in this paper can provide real help in the public safety need for a drugged driving policy that reduces the number of drugged driving accidents on the road.
New research appearing online today in Clinical Chemistry, the journal of AACC, shows that decreased levels of vitamin D may predispose smokers to developing tobacco-related cancer. This study illustrates that simple vitamin D blood tests and supplements have the potential to improve smokers’ health.
Breaking research appearing online today in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.
AACC is pleased to announce the addition of a late-breaking session, The Supreme Court Decision on Human Gene Patents and Its Implications, to its scientific program at the 2013 AACC Annual Meeting & Clinical Lab Expo in Houston.
Selected research being presented at the 2013 AACC Annual Meeting includes new tests to detect life-threatening prostate cancer, new cystic fibrosis tests that can be measured at the point of care, and new ways to determine the safety of drugs used to treat schizophrenia and bipolar disorder.
The ultimate solution for multiplex assays, QuantiScientifics new A2 Micro Array System provides user-defined, high-throughput, high-performance assays utilizing DNA and antibody links.
Created to help laboratory medicine trainees prepare for board examinations in the U.S. and U.K., the Question Bank is the most extensive compilation of board study questions ever collected.
AACC’s Pediatric Reference Range Committee (PRRC) is performing two pilot studies to establish crucial pediatric reference intervals as part of the National Children’s Study.
Lab Tests Online, the world’s leading website for patient health literacy on laboratory testing, is pleased to announce that it has reached a major milestone—serving its 150 millionth visitor.
AACC today announced that it has awarded its advertising business to Cunningham Associates, effective October 1.
AACC welcomed more than 17,500 medical professionals to the association’s 63rd Annual Meeting and Clinical Lab Expo from July 28–August 1. This dynamic convention offered attendees five days packed with information on international trends and breaking science in laboratory medicine, as well as the chance to see new technology at the world’s largest clinical laboratory exposition and network with global leaders in the field.
A study appearing online today in Clinical Chemistry, the journal of AACC, shows for the first time that low quality commercial lab kits may be one factor hampering the progress of cancer diagnostics.
AACC is pleased to announce that four new members have been elected to the association’s Board of Directors and will begin serving in January 2014. The AACC membership also elected two new members to the Nominating Committee.
AACC is pleased to announce the launch of the Question Bank, an innovative online tool that will make it significantly easier for laboratory medicine trainees to prepare for U.S. and U.K. board examinations.
AACC is pleased to announce that the AACC Annual Meeting & Clinical Lab Expo won the 2013 Trade Show News Network (TSNN) award for having the fastest growing attendance of all nonprofit trade shows. The AACC Annual Meeting is also known for being the world’s largest diagnostics conference and expo.
AACC has released a position statement on harmonization of—or ensuring uniformity among—clinical laboratory test results to help patients receive appropriate diagnoses and medical treatment. With this statement, the association aims to raise awareness about this essential healthcare issue and urge the medical community to work together to make harmonization a reality.
The new special “Advancing Women’s Health” issue of Clinical Chemistry, the journal of AACC, showcases nearly 50 studies that close the gap between men’s and women’s healthcare by shedding light on how heart disease, cancer, reproductive problems, and other common health issues manifest differently in women than in men at the molecular and genetic level.
Two new papers in the “Advancing Women’s Health” issue of Clinical Chemistry, the journal of AACC, show for the first time that measuring the amount of certain protein fragments and microRNAs in a woman’s blood and breast tissue might enable the early diagnosis of breast cancer or prediction of its metastasis, respectively.
The symptoms of heart disease are often less obvious in women than in men, and as a result, some experts have recommended changing current medical practice and using separate criteria to identify the disease and predict its progression in women. However, new findings in the “Advancing Women’s Health” issue of Clinical Chemistry, the journal of AACC, suggest that sex-specific criteria do not improve the prognostic accuracy of blood tests for diagnosing heart disease.
A new Q&A in the “Advancing Women’s Health” issue of Clinical Chemistry, the journal of AACC, explores the ethics of preimplantation genetic diagnosis, a form of genetic testing that has already made it possible for parents to conceive a child who is a donor match for a sick relative, who shares their minor disability (such as deafness), or to select gender.
On January 29, the U.S. Senate passed the Newborn Screening Saves Lives Reauthorization Act of 2013 (S.1417) by unanimous consent. AACC applauds the Senate’s approval of this legislation, which is integral to improving children’s health, and urges the U.S. House of Representatives to pass it as well.
Today, HHS announced a ruling that allows patients direct access to their completed test reports. AACC supports this new ruling and applauds the ongoing efforts of HHS to empower patients to be informed healthcare consumers.
AACC is pleased to announce the recipients of the 2014 AACC Awards. Each year, AACC recognizes individuals from around the world for their superior contributions to the field of laboratory medicine with its awards program, which aims to encourage excellence within the profession and raise awareness about the importance of clinical laboratory science to improving healthcare.
On February 26, AACC will host a webinar with Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics in the Center for Devices and Radiological Health at FDA to discuss FDA’s guidance on in vitro diagnostic products labeled for research use only (RUO) or investigational use only (IUO).
The President’s budget proposes cuts to laboratory reimbursement that could have a significant impact on patient health by hindering the development and implementation of new technologies, reducing the number of laboratories serving underserved populations, decreasing patient access to such vital tests as hepatitis C and cancer screenings, and diminishing the quality of testing.
On March 19, AACC will host a webinar with FDA division director Courtney Lias, PhD, about FDA’s new draft guidance proposing separate performance and accuracy criteria for over-the-counter blood glucose meters used in the home and prescription point-of-care blood glucose meters used in the hospital.
Though the 11 most popular hospital urine pregnancy tests perform well in the first month after conception, a new study published in Clinical Chemistry, the journal of AACC, reveals the alarming statistic that nine of these tests become significantly more likely to produce false-negative results after the 5th to 7th week of pregnancy.
In November 2013, the U.S. Food and Drug Administration (FDA) ordered the company 23andMe to stop offering its direct-to-consumer DNA testing service, which provided individuals with $99 assessments of their genetic risk for almost 200 disorders. A thought-stimulating opinion piece published in Clinical Chemistry, the journal of AACC, now examines whether this move by FDA is a violation of the First Amendment, or a necessary step to protect consumers.
On May 7, AACC will host a webinar about the Protecting Access to Medicare Act of 2014, a new law signed by the president on April 1 that will make the most significant changes to medical test reimbursement that clinical laboratories have seen in 3 decades.
In January, the U.S. Food and Drug Administration (FDA) released draft guidance proposing separate performance and accuracy criteria for over-the-counter blood glucose meters used in the home and prescription blood glucose meters used in hospitals. AACC supports FDA’s initiative to improve the quality of these devices and enhance patient care, but recommends revising this draft guidance to ensure that it does not unnecessarily increase the regulatory burden and costs on the healthcare system.
In March of this year, a team of Georgetown University scientists published research showing that, for the first time ever, a blood test has the potential to predict Alzheimer’s disease before patients start showing symptoms. AACC is pleased to announce that a late-breaking session at the 2014 AACC Annual Meeting & Clinical Lab Expo in Chicago will expand upon this groundbreaking research and discuss why it could be the key to curing this devastating illness.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right